Subscribe
shutterstock_1833687988_rafapress
rafapress / Shutterstock.com
7 July 2022Big Pharma

CureVac sues BioNTech over mRNA technology

Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid (mRNA) technology.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
Medtech firm faces lawsuit over COVID–19 design
2 August 2022   Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.
Big Pharma
Big pharma firm hits back in COVID-19 tech dispute
6 September 2022   CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid
Big Pharma
Pfizer and partner hit back in COVID-19 vaccine dispute
8 December 2022   Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Medtech
Medtech firm faces lawsuit over COVID–19 design
2 August 2022   Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.
Big Pharma
Big pharma firm hits back in COVID-19 tech dispute
6 September 2022   CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid
Big Pharma
Pfizer and partner hit back in COVID-19 vaccine dispute
8 December 2022   Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.

More on this story

Medtech
Medtech firm faces lawsuit over COVID–19 design
2 August 2022   Leading healthcare tech company accused of infringing COVID-19 test design | Cellex has asked court for injunctive relief | Siemens.
Big Pharma
Big pharma firm hits back in COVID-19 tech dispute
6 September 2022   CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid
Big Pharma
Pfizer and partner hit back in COVID-19 vaccine dispute
8 December 2022   Big pharma firm accused of copying technology when developing vaccine | Dispute will also play out in Germany | BioNTech | Moderna.

More features

President Trump 2.0: Five major areas to watch
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court